Search Results
Results found for "Bryan L Roth"
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
simulations which revealed different trajectories passing through the gap between TM helices IV and V for both
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
validity as a fluorescent probe for Tag-lite® assays, where we used a set of 7 cannabinoid ligands (both
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
Inside the Lesson: Antagonist Behavior by the Numbers Terry walks through both the pharmacologic and
- Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...
In contrast to wild type CXCR4, both R334X and S339fs5 were largely insensitive to CXCL12-promoted degradation
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
chemokine receptor axes play a pivotal role in the recruitment and oriented trafficking of immune cells both
- Melatonin MT 2 receptor is expressed and potentiates contraction in human airway smooth muscle
mediated via its specific G protein-coupled receptors (GPCRs) named the MT1 receptor, which couples to both
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
the movement of Switch II towards the nucleotide-binding pocket and the stabilization of Switch III, both
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
activation of cytosolic effector proteins: the G proteins after which GPCRs are named, and arrestins which both points of contact it is possible not only to strongly increase binding affinity but also to fine tune both transmembrane domain providing significantly increased binding affinity and providing a means to control both Both properties enable enhanced ligands to avoid being eliminated during the stringent washing process at killing cells than unconjugated MMAE, the Orion CCL5 superagonist analog significantly increased both
- Innovative Data-Driven Solutions: The pHSense Revolution
They learned how to fine-tune both brightness and fluorescence lifetime.
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Instead of chasing linear progress, Eric encourages young scientists to stay playful longer—embracing both
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
For Catherine, it became both—after years of uncertainty, pivots, and practical lab experience that grounded
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
Lessons From the Front Lines of Biotech Ajay’s experience in both early-stage biotech and academic science
- Your GPCR Program Decisions Depend on Good Data Interpretation
Katerina Leftheris : New technologies overcoming peptide limitations with insights from both pharma and
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Both orphan and well-characterized GPCRs are untapped opportunities for drug development targeting CNS
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
Check out what’s coming in September and October: Sign up for both courses now and score a 25% early
- Why Opposing Processes Matter for Your Next GPCR Drug
Constitutive Activity: When Doing Nothing Still Does Something Some GPCRs simply refuse to stay quiet
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
localization, trafficking, and dynamics—if your probes preserve function, minimize phototoxicity, and work in both
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
suppresses inhalation while xylazine prolongs exhalation, creating a respiratory cycle that collapses from both
- 📰 GPCR Weekly News, August 28 to September 3, 2023
stimulates human ovarian cancer cell invasion by upregulating MMP-9 via ERK1/2 signaling CCR7 acts as both
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
diabetic models have shown that although exendin-P5 induces lower insulin release compared to exendin, both
- Therapeutic validation of an orphan G protein‐coupled receptor
GPR84 is a promising target to exploit and the investment in better tools to study its function in both
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
Patients with Acute Burn Injuries Carmot Therapeutics Enters into Definitive Merger Agreement with Roche
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Become a Premium Member to access both courses at a reduced price.
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Both BERKY and ONE-GO biosensors are engineered to detect the GTP-bound Gα subunit, serving as a proxy
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Both can result in a positive inotropic effect.
- 📰 GPCR Weekly News, May 6 to 12, 2024
Stay tuned as we plan to open registrations for both classes in July 2024. Dr.















